Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice

  • Alexandra Cambier,
  • Jennifer Da Silva,
  • Julie Bex,
  • Fanny Canesi,
  • Lison Lachize Neanne,
  • Aurélie Sannier,
  • Hélène Mathieu,
  • Erwan Boedec,
  • Amandine Badie,
  • Renato C. Monteiro

The fifth author’s initials appear incorrectly in the citation. The correct citation is: Cambier A, Da Silva J, Bex J, Canesi F, Lachize Neanne L, Sannier A, et al. (2025) Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. PLoS One 20(10): e0318581. https://doi.org/10.1371/journal.pone.0318581.

A second affiliation for the fifth author is not indicated. Lison Lachize Neanne is also affiliated with: Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte-Justine, Montréal, Canada.

Reference

  1. 1. Cambier A, Da Silva J, Bex J, Canesi F, Neanne LL, Sannier A, et al. Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. PLoS One. 2025;20(10):e0318581. pmid:41056297

Citation: Cambier A, Da Silva J, Bex J, Canesi F, Neanne LL, Sannier A, et al. (2026) Correction: Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. PLoS One 21(3): e0345118. https://doi.org/10.1371/journal.pone.0345118

Published: March 17, 2026

Copyright: © 2026 Cambier et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.